A Clinical Study to Assess the Efficacy & Safety of Dexamethasone

Clinical Trial Summary

Patients at least 40 years of age who are undergoing cataract surgery will be randomized to receive treatment with one of two dose levels of dexamethasone ophthalmic suspension eye drops to determine if the drops decrease inflammation inside the eye and are safe after cataract surgery.

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03677700` - Evaluation of Inflammation of the Anterior Segment by Laser Flashmeter in Patients Having Undergone Surgery of the Posterior Segment (Vitrectomy or Preindentation) During the First Postoperative Year. (FLAVIC)
Completed	`NCT03317847` - Bromfenac Versus Dexamethasone After Cataract Surgery	Phase 4
Recruiting	`NCT06128369` - Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery	Phase 3

See also

Status

Clinical Trial

Phase

Not yet recruiting

NCT03677700 - Evaluation of Inflammation of the Anterior Segment by Laser Flashmeter in Patients Having Undergone Surgery of the Posterior Segment (Vitrectomy or Preindentation) During the First Postoperative Year. (FLAVIC)

Completed

NCT03317847 - Bromfenac Versus Dexamethasone After Cataract Surgery

Phase 4

Recruiting

NCT06128369 - Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

Phase 3

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03687931
Study type	Interventional
Source	iDrop, Inc.
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	August 26, 2018
Completion date	February 28, 2019

A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms